| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.7M | — | +20.3% |
| Gross Profit | $2.7M | — | -39.4% |
| R&D Expense | $2.8M | — | -7.1% |
| SG&A Expense | $6.5M | — | -24.7% |
| Operating Income | -$14.9M | — | -18.3% |
| Pre-tax Income | -$14.0M | — | -22.1% |
| Income Tax | -$1.8M | — | -10.7% |
| Net Income | -$12.3M | — | -24.0% |
| EPS (Basic) | -$0.23 | — | -27.8% |
| EPS (Diluted) | -$0.23 | — | -27.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $50.1M | +4.2% | +2.0% |
| Short-term Investments | $36.0M | +32.6% | +4.7% |
| Accounts Receivable | $38.9M | -49.2% | +20.2% |
| Inventory | $30.9M | +27.3% | -4.7% |
| Current Assets | $161.1M | -11.1% | +4.2% |
| Total Assets | $209.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $21.0M | — | +97.0% |
| Capital Expenditures | $814K | — | +326.2% |
| Investing Cash Flow | -$7.6M | — | -160.0% |
| Financing Cash Flow | -$11.4M | — | -193.6% |
| Free Cash Flow | $20.2M | — | +92.8% |
| -7.3% |
| Current Liabilities | $17.4M | -0.0% | -5.9% |
| Total Liabilities | $24.7M | -2.4% | -9.4% |
| Stockholders' Equity | $184.3M | -10.6% | -7.0% |